CEBPZ recruits METTL3 to the SP1 promoter area to increase m6A levels and induce translation, and SP1 subsequently activates c-MYC, a notorious oncogene, resulting in the formation of AML. The gene discussed is SP1; the disease is acute myeloid leukemia.